http://www.topotarget.com/Oncology studies in small molecule histone deacetylase and topoisomerase II inhibitors, with clinical trials in solid tumours, CNS and extravasation. Technology and profile of company with facilities in Copenhagen and Abingdon, England.CancerTopotarget is a Scandinavian based oncology
Topotarget aims at improving quality of and prolonging life of
by offering novel, safe and effective cancer
is a Histone Deacetylases
being tested in a number of clinical trials.
Media enquiries should be directed to CEO Francois
Investor and Public
For detailed information visit the website, please...WelcometoTopotargetTopotarget
Oncology studies in small molecule histone deacetylase and topoisomerase II inhibitors, with clinical trials in solid tumours, CNS and extravasation. Technology and profile of company with facilities in Copenhagen and Abingdon, England.
Company developing gene therapy system, using the E. coli enzyme, purine nucleoside phosphorylase, to induce suicide in tumor cells. Includes technology background, research, patents, publications, key staff, and contacts in Birmingham, Alabama.
Joining mailing list will entitle you
to receive occasional emails informing you of news and
updates to the site and any special offers that may be
of interest to you.